ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 748533 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 748533; 2) Community: the network communities that were significantly associated with the response to NSC 748533; 3) Molecule: the relationships between components within communities and NSC 748533; 4) MDR: the compounds that were significantly associated with the NSC 748533.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.043472147060915 -0.042221775
NSC 715135 Null 0.043472147060915 -0.02866049
NSC 717468 Null 0.043472147060915 0.10691122
NSC 718781 Erlotinib hydrochloride 0.043472147060915 -0.12080079
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.043472147060915 0.12427938
NSC 720495 Null 0.043472147060915 0.35686425
NSC 727113 Null 0.043472147060915 0.12174877
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.043472147060915 0.34915147
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.043472147060915 0.093330532
NSC 743532 Null 0.043472147060915 -0.25970543
Total:107  Current:83    [First] [Prev] [Next] [Last]